Sign up for the QMED & MD+DI Daily newsletter.
Trelleborg Preps for MD&M & Other Supplier News
Keeping you up to date on the latest supplier news.
September 21, 2023
Trelleborg Healthcare & Medical exhibits advanced polymer solutions for healthcare and medical devices, and pharmaceutical and biotech applications, at MD&M Minneapolis in Minneapolis, Minnesota, October 10 to 11, 2023, in Booth 3202.
On display are solutions offered by Trelleborg’s Innovation Center which reduce manufacturers’ time to market. Also featured are Trelleborg’s advanced capabilities in biopharmaceutical processing, thermoplastic injection molding, tubing, hose, molded parts, multi-component and micromolding offerings.
Chris Tellers, Global Technology Director, Healthcare & Medical, says: “For healthcare and medical innovators looking to create high-performing products and measurably reduce go-to-market timelines, our team at the Innovation Center can create samples in days, enabling multiple design iterations to be tested to confirm effective production and rapid scale up. Engineers and product innovators get direct access to some of the best minds in materials science, design for manufacturability, tooling and prototyping, plus proven processes for improving critical outcomes in development and manufacturing.”
Another highlight is Trelleborg’s BioPharmaPro range for individual single-use fluid path components, complex assemblies, and full biopharmaceutical systems. BioPharmaPro™ products are manufactured from a wide portfolio of polymer materials meeting functionality, cleanliness and sterilization, and regulatory requirements.
Mike Urbanski, Business Development Manager for Biopharma, says: “The combination of polymer materials expertise, advanced manufacturing processes, innovative engineering and quality assurance provided through BioPharmaPro enables us to provide unsurpassed support to accelerate the business of our biopharmaceutical customers. It adds value for customers through our one-stop shop for integrated solutions, from simple products to complex assemblies, allowing system suppliers to focus on drug development while outsourcing the product engineering and consolidating their supply chain.”
Also displayed are molded parts used in implantable healthcare and medical devices alongside multicomponent and micromolding capabilities.
Andrew Gaillard, Global Commercial Director, Healthcare & Medical, said in a release that: “One of our most successful capabilities is the combination of liquid silicone rubber (LSR) with plastics. Commonly referred to as 2C or 2-shot, multicomponent injection molding enables our LSR experts to employ highly sophisticated tool and process engineering to develop innovative solutions that combine two or more individual materials into one fully bonded, robust component.”
For further details about Trelleborg Healthcare & Medical, go to www.trelleborg.com/healthcare
START SLIDESHOW ›
About the Author(s)
You May Also Like
Empatica Launch Next-Gen FDA-Cleared Epilepsy WatchMar 1, 2024|2 Min Read
Safeguard Medical Devices: A Complete Approach to Device Lifecycle SecurityApr 4, 2024|13:00 EDT
Boston Sci Nabs FDA Approval for Agent DCBMar 1, 2024|2 Min Read
Masimo Takes Apple's Hail Mary Pass in StrideFeb 29, 2024|3 Min Read